Perry Disease: Bench to Bedside Circulation and a Team Approach

Area of Science:

• Neuroscience
• Genetics
• Rare Diseases

Background:

• Technological advancements have identified new rare diseases, but their pathogenesis and treatment remain under-researched compared to common diseases.
• Perry disease, a rare autosomal dominant neurodegenerative disorder, presents with parkinsonism, depression, weight loss, and respiratory issues.
• Pathologically, Perry disease is classified under TAR DNA-binding protein 43 (TDP-43) proteinopathies and is caused by DCTN1 gene mutations.

Purpose of the Study:

• To highlight the importance of rare disease research using Perry disease as a model.
• To review current knowledge on Perry disease from basic and clinical research.
• To discuss technological innovations, challenges, and treatment prospects for rare neurodegenerative disorders.

Main Methods:

• Literature review focusing on Perry disease research.
• Analysis of clinical and pathological features associated with DCTN1 mutations.
• Discussion of technological advancements in rare disease research.

Main Results:

• Perry disease is characterized by specific clinical and pathological features linked to DCTN1 mutations.
• Recent findings provide insights into the pathogenesis and genetic basis of Perry disease.
• Technological innovations are improving the study of rare diseases.

Conclusions:

• Research into rare diseases like Perry disease is crucial for understanding broader neurological conditions.
• Collaboration between clinicians and researchers is vital for advancing rare disease research.
• Studying rare diseases opens new avenues for scientific exploration and potential treatments for both rare and common diseases.